Researchers lead by Technion Professor Shulamit Levenberg, who specialises in tissue engineering, have succeeded in establishing a hierarchical blood artery network, crucial for giving blood to implanted tissue. In the research published in Advanced Materials, Dr. Ariel Alejandro Szklanny employed 3D printing for constructing huge and small blood arteries to form for the first time a system that comprised a functioning combination of both. The breakthrough took accomplished in Prof. Levenberg’s Stem Cell and Tissue Engineering Laboratory in the Technion’s Faculty of Biomedical Engineering.
The heart pumps blood into the aorta, which branches out into progressively smaller blood arteries, bringing oxygen and nutrients to all the tissues and organs. Transplanted tissues, as well as tissues created for transplantation, require similar blood vascular support.
Previous experiments with synthetic tissue containing hierarchical vessel networks have involved an intermediary step of transplanting first into a healthy limb, enabling it to be infiltrated by the host’s blood vessels, and then transferring the structure into the damaged location.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
Notably, whereas prior studies employed animal collagen to create the scaffolds, the Israeli company CollPlant modified tobacco plants to make human collagen, which was successfully used for 3D bioprinting the vascularized tissue structures.
This study is a significant step forward in the direction of individualized medicine. Large blood vessels with the precise shape required can be manufactured and inserted alongside the tissue to be implanted. This tissue can be created using the patient’s own cells, hence avoiding the possibility of rejection.
Notably, whereas prior studies employed animal collagen to create the scaffolds, the Israeli company CollPlant modified tobacco plants to make human collagen, which was successfully used for 3D bioprinting the vascularized tissue structures.
This study is a significant step forward in the direction of individualized medicine. Large blood vessels with the precise shape required can be manufactured and inserted alongside the tissue to be implanted. This tissue can be created using the patient’s own cells, hence avoiding the possibility of rejection.
